Mori Nobuaki

Researcher

基本情報

Profile and Settings

• 氏名

  Mori Nobuaki

Affiliation

• Infectious Diseases Internal Medicine, Associate Professor

Location

• University Hospital

Degree

• Aug. 2012

Committee Memberships

• Jul. 2014, Jun. 2018
• Apr. 2016
• Apr. 2016
• Aug. 2017
• Apr. 2018
• Feb. 2021
• Apr. 2022
• Dec. 2022
• Dec. 2022
• Feb. 2023

Achievements

Published Papers

• Association between 16S rRNA variation patterns and mgpB phylogeny in Mycoplasma genitalium., Imai Kazuo;Omachi Ryuha;Sato Akihiro;Tanaka Masashi;Mori Nobuaki;Maeda Takuya, Microbiology spectrum, May 2026, Peer-reviewed
• One Health genomic insights into environmental and animal reservoirs of community-associated Clostridioides difficile in Japan., Yoshizawa S, Komori K, Aoki K, Sawa T, Sasaki Y, Kurosaki Y, Murata Y, Kasai T, Mori N, Asai T, Ishii Y, Tateda K., Appl Environ Microbiol., May 2026, Peer-reviewed
• Host control of persistent Epstein-Barr virus infection., Schmidt A, Alawathurage TM, David FS, Ogawa Y, Frach L, Richter S, Schaefer M, Mathey CM, Henne SK; Japan COVID-19 Task Force; Forstner AJ, Dilthey AT, Pröbstel AK, Boztug K, Nöthen MM, Namkoong H, Okada Y, Beins EC, Ludwig KU., nature, 653(8114):444 - 454, May 2026, Peer-reviewed
• Clinical epidemiology and management challenges of genital Mycoplasma and Ureaplasma infections: a retrospective observational study at a Japanese urban clinic., Mori Nobuaki;Yukawa Kenya;Oda Masahito;Tanaka Masashi;Tokimatsu Issei;Sato Akihiro, Sexual health, 23(2), Apr. 2026, Peer-reviewed
• Evaluation of Antibiotic Use Metrics as Predictors of Clostridioides difficile Infection Onset: A Single-Center, Case-Control Study Assessing the Days of Therapy and the Days of Antibiotic Spectrum Coverage., Maeda Masayuki;Mori Nobuaki;Hiraide Miki;Oda Masahito;Yamaguchi Kozue;Tokimatsu Issei, Biological & pharmaceutical bulletin, 49(3), Mar. 2026, Peer-reviewed
• Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023-2025., Omachi Ryuha;Imai Kazuo;Sato Akihiro;Tanaka Masashi;Mizushina Hitomi;Takeuchi Keita;Mori Nobuaki;Maeda Takuya, Antimicrobial agents and chemotherapy, 70(2), Feb. 2026, Peer-reviewed
• Antimicrobial stewardship among Japanese obstetricians and gynecologists: A nationwide questionnaire-based survey of knowledge, awareness, and practice., Mori Nobuaki;Miyazaki Hiroaki;Noguchi Yasuyuki;Iino Kaori;Mikamo Hiroshige;Higuchi Tsuyoshi, Journal of infection and chemotherapy, 31(11), Nov. 2025, Peer-reviewed
• dentification and replication of sex-dimorphic protein quantitative trait loci across multiple ancestries and their associations with diseases., Bhak Y, Raptis V, He Y, Nakanishi T, Macdonald-Dunlop E, Sagiya Y, Morisaki T, Matsuda K; BioBank Japan Project; Japan COVID-19 Task Force; Kanai A, Suzuki Y, Oda Y, Kamatani Y, Namkoong H, Saiki R, Kimura A, Koike R, Ogawa S, Miyano S, Imoto S, Kanai T, Fukunaga K, Okada Y, Mälarstig A, Tenesa A., Sci Rep, Aug. 2025, Peer-reviewed
• Deciphering state-dependent immune features from multi-layer omics data at single-cell resolution., Edahiro R, Sato G, Naito T, Shirai Y, Saiki R, Sonehara K, Tomofuji Y, Yamamoto K, Namba S, Sasa N, Nagao G, Wang QS, Takahashi Y, Hasegawa T, Kishikawa T, Suzuki K, Liu YC, Motooka D, Takuwa A, Tanaka H, Azekawa S; Japan COVID-19 Task Force; Namkoong H, Koike R, Kimura A, Imoto S, Miyano S, Kanai T, Fukunaga K, Uemura M, Morita T, Kato Y, Hirata H, Takeda Y, Doki Y, Eguchi H, Okuzaki D, Sakakibara S, Ogawa S, Kumanogoh A, Okada Y., Nat Genet., Aug. 2025, Peer-reviewed
• Influence of renal function and daptomycin dose on clinical effectiveness and adverse events in Japanese pediatric patients: A multicenter retrospective observational study., Shiraishi C, Kato H, Hirai J, Nishiyama N, Inagaki T, Ashizawa N, Nakamatsu M, Yamamoto K, Miyagawa Y, Honda H, Kakiuchi S, Fujita A, Tashiro M, Tanaka T, Izumikawa K, Hagihara M, Asai N, Mori N, Mikamo H, Iwamoto T., PLoS One, Jul. 2025, Peer-reviewed
• Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial., Kita T, Ohmagari N, Saito S, Mukae H, Takazono T, Nakada TA, Shimada T, Hirai Y, Shindo Y, Komiya K, Saito A, Yamato M, Homma K, Okamoto M, Yamamoto Y, Mutoh Y, Hasegawa C, Mori N, Nakamura-Uchiyama F, Honda M, Tomii K, Ishii H, Takajo I, Watanabe K, Kitamura K., Viruses, 17(7):982, Jul. 2025, Peer-reviewed, DOI:doi: 10.3390/v17070982
• Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial., Kita T, Ohmagari N, Saito S, Mukae H, Takazono T, Nakada TA, Shimada T, Hirai Y, Shindo Y, Komiya K, Saito A, Yamato M, Homma K, Okamoto M, Yamamoto Y, Mutoh Y, Hasegawa C, Mori N, Nakamura-Uchiyama F, Honda M, Tomii K, Ishii H, Takajo I, Watanabe K, Kitamura K., Viruses., Jul. 2025, Peer-reviewed
• A web questionnaire-based survey on post-COVID-19 condition for infectious disease specialists in Japan., Mori N, Mikamo H, Kunishima H, Yanagihara K, Sasaki J, Mukae H, Yotsuyanagi H, Hasegawa N, J Infect Chemother, May 2025, Peer-reviewed
• Days of antibiotic spectrum coverage (DASC) as predictors of recurrent Clostridioides difficile infection: A retrospective cohort study., Mori N, Shibata Y, Hirai J, Asai N, Mikamo H., J Infect Chemother, Apr. 2025, Peer-reviewed
• Pyogenic vertebral osteomyelitis and iliopsoas muscle abscess caused by non-typhoidal Salmonella rapidly identified by genetic testing in an immunocompetent teenage boy without hemoglobinopathies, Hirai J, Mori N, Sakanashi D, Shibata Y, Asai N, Hagihara M, Mikamo H., IDCases, Apr. 2025, Peer-reviewed
• Clinical efficacy and safety assessment of tedizolid using therapeutic drug monitoring, Shibata Y, Shiota A, Mori N, Asai N, Hagihara M, Mikamo H., J Infect Chemother., Mar. 2025, Peer-reviewed
• A successful diagnostic case of Varicella zoster virus pneumonia by a Film Array assay for meningitis/encephalitis., Asai N, Yamada A, Nakamura A, Ohno T, Miyazaki N, Kawamoto Y, Takayama M, Sakanashi D, Ohta T, Shibata Y, Kato H, Hagihara M, Mori N, Mikamo H, Respir Med Case Rep., Feb. 2025, Peer-reviewed
• Evaluating Bezlotoxumab-Fidaxomicin Combination Therapy in Clostridioides Infection: A Single-Center Retrospective Study from Aichi Prefecture, Japan, Hirai J, Mori N, Hanai Y, Asai N, Hagihara M, Mikamo H, Antibiotics, Feb. 2025, Peer-reviewed
• Blood DNA virome associates with autoimmune diseases and COVID-19., Sasa N, Kojima S, Koide R, Hasegawa T, Namkoong H, Hirota T, Watanabe R, Nakamura Y, Oguro-Igashira E, Ogawa K, Yata T, Sonehara K, Yamamoto K, Kishikawa T, Sakaue S, Edahiro R, Shirai Y, Maeda Y, Nii T, Chubachi S, Tanaka H, Yabukami H, Suzuki A, Nakajima K, Arase N, Okamoto T, Nishikawa R, Namba S, Naito T, Miyagawa I, Tanaka H, Ueno M, Ishitsuka Y, Furuta J, Kunimoto K, Kajihara I, Fukushima S, Miyachi H, Matsue H, Kamata M, Momose M, Bito T, Nagai H, Ikeda T, Horikawa T, Adachi A, Matsubara T, Ikumi K, Nishida E, Nakagawa I, Yagita-Sakamaki M, Yoshimura M, Ohshima S, Kinoshita M, Ito S, Arai T, Hirose M, Tanino Y, Nikaido T, Ichiwata T, Ohkouchi S, Hirano T, Takada T, Tazawa R, Morimoto K, Takaki M, Konno S, Suzuki M, Tomii K, Nakagawa A, Handa T, Tanizawa K, Ishii H, Ishida M, Kato T, Takeda N, Yokomura K, Matsui T, Uchida A, Inoue H, Imaizumi K, Goto Y, Kida H, Fujisawa T, Suda T, Yamada T, Satake Y, Ibata H, Saigusa M, Shirai T, Hizawa N, Nakata K; Japan COVID-19 Task Force; Imafuku S, Tada Y, Asano Y, Sato S, Nishigori C, Jinnin M, Ihn H, Asahina A, Saeki H, Kawamura T, Shimada S, Katayama I, Poisner HM, Mack TM, Bick AG, Higasa K, Okuno T, Mochizuki H, Ishii M, Koike R, Kimura A, Noguchi E, Sano S, Inohara H, Fujimoto M, Inoue Y, Yamaguchi E, Ogawa S, Kanai T, Morita A, Matsuda F, Tamari M, Kumanogoh A, Tanaka Y, Ohmura K, Fukunaga K, Imoto S, Miyano S, Parrish NF, Okada Y., Nat Genet., Jan. 2025, Peer-reviewed
• Clinical characteristics and antimicrobial susceptibility of Eggerthella lenta infection over a 5-year trend at a university hospital in Japan., Mori N, Nakamura A, Hirai J, Asai N, Shibata Y, Takayama M, Kawamoto Y, Miyazaki N, Sakanashi D, Ohno T, Yamada A, Suematsu H, Koita I, Chida S, Ohta T, Mikamo H., Nagoya J Med Sci., Nov. 2024, Peer-reviewed
• Effects of Adding P2Y12 Inhibitor to Anti-staphylococcal Therapy on Bacterial Clearance in Patients With Staphylococcus aureus Bacteremia., Mori N, Shibata Y, Ohashi W, Hirai J, Asai N, Mikamo H., Cureus, Oct. 2024, Peer-reviewed

Presentations

• アゾール耐性Candida albicansによる腎膿瘍の耐性機序解析とFLCZ組織移行性の検討, 森伸晃、庄司稜涼、石野敬子、前田真之、尾田正仁、時松一成, 第45回関東医真菌懇話会., 27 Jun. 2026
• カルバペネム耐性腸内細菌目細菌の届出基準変更前後でみた当院における分離状況, 尾田 正仁、森 伸晃、橋口 深雪、前田 真之、石野 敬子、時松 一成, 第100回日本感染症学会学術講演会 第74回日本化学療法学会総会 合同学会, 23 May 2026
• Molecular epidemiology and antimicrobial resistance of Mycoplasma genitalium in Tokyo, 2023-2025., Omachi R, Imai K, Sato A, Tanaka M, Mori N, Maeda T, ESCMID global 2026, 20 Apr. 2026
• 医療ビッグデータを用いたインフルエンザ治療薬のフォーミュラリ策定, 吉川 雅之, 中山華, 若林仁美, 永田未希, 松崎あい理, 中村彰子,古屋宏章, 内倉健, 百賢二, 嶋村弘史, 森伸晃, 時松一成, 田中克巳., 日本薬学会第146年会, 26 Mar. 2026
• 小児における2剤耐性緑膿菌による生体弁付き導管感染に対しセフトロザン・タゾバクタムを長期使用した一例, 尾田正仁, 森伸晃, 時松一成, 第95回日本感染症学会西日本地方会学術集会・第73回日本化学療法西日本支部総会., 15 Feb. 2026
• 感染症医が不在となる医療機関への遠隔医療支援　遠隔医療の現状と感染症診療への応用の可能性, 森 伸晃, 日本臨床微生物学会, Dec. 2025
• Klebsiella pneumoniaeによる人工弁感染性心内膜炎の一例., 尾田正仁, 森伸晃, 前田真之, 石野敬子, 時松一成., 第95回日本感染症学会西日本地方会学術集会・第73回日本化学療法西日本支部総会., 29 Nov. 2025
• 感染症の動向と平時からの準備について., 森伸晃, 令和7年度相模原市新興感染症机上訓練., 30 Oct. 2025
• アゾール耐性Candida albicansによる腎膿瘍の一例：尿路および腎組織中のFLCZ濃度測定と治療効果の検討, 森伸晃, 尾田正仁, 松元加奈, 前田真之, 石野敬子, 森田邦彦, 時松一成., 第74回日本感染症学会東日本地方会学術集会・第72回日本化学療法学会東日本支部総会 合同学会., 26 Sep. 2025
• A retrospective study of clinical characteristics and treatment outcomes of sexually transmitted Mycoplasma and Ureaplasma species in a Japanese clinic, 2023-2024, Mori. N, Yukaw K, Oda M, Tanaka M, On R, Tokimatsu I, Sato A., ASM microbe, 20 Jun. 2025
• シンポジウム CDI治療薬: フィダキソマイシンと新規治療薬の展望., 森伸晃, 第99回日本感染症学会総会学術講演会・第73回日本化学療法学会合同学会, 08 May 2025
• 日本のクリニックにおける性感染性マイコプラズマ・ウレアプラズマの実態調査　2023-2024年の後方視的研究, 森 伸晃;湯川 堅也;田中 雅之;温 麟太郎;時松 一成;佐藤 昭裕, 日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会, Apr. 2025
• 初めての論文投稿を成功させる　査読者の視点と実践的アドバイス, 森 伸晃, 日本臨床微生物学会雑誌, Dec. 2024

MISC

• 【感染症・抗菌薬・抗微生物薬2026】総論　新興再興感染症とパンデミック対策, 森 伸晃;時松 一成, 救急・集中治療, 37(5-6):819, Feb. 2026
• ICT・ASTのための3分で学べる今月の細菌(第12回)　クロストリディオイデス・ディフィシル, 森 伸晃, INFECTION CONTROL, 34(12):1164, Dec. 2025
• 【消化管感染症のすべて2025】総論　腸管感染症の治療(JAID/JSC感染症治療ガイドライン2023,Clostridioides difficile感染症ガイドライン2022も含めて), 森 伸晃, 消化器内視鏡, 37(増刊):35, Dec. 2025
• 今月の!検査室への質問に答えます　Clostridioides difficile感染症(CDI)の治療について,日本における分離株の特徴を踏まえつつ教えてください, 森 伸晃, 臨床検査, 69(9):1014, Sep. 2025
• 【抗菌薬の選び方・変え方・やめ方】抗菌薬の選び方　薬剤編　バンコマイシン,ダプトマイシン, 森 伸晃, Medicina, 62(6):784, May 2025